E. Bøg-Hansen

Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with Type 2 diabetes. The Skaraborg Project

L. Råstam, U. Lindblad, J. Hedner, 2005, Diabetic medicine : a journal of the British Diabetic Association.

Risk factor clustering in patients with hypertension and non‐insulin‐dependent diabetes mellitus. The Skaraborg Hypertension Project

J. Ranstam, L. Råstam, U. Lindblad, 1998, Journal of internal medicine.

Survival in patients with hypertension treated in primary care A population-based follow-up study in the Skaraborg Hypertension and Diabetes Project

L. Råstam, U. Lindblad, B. Gullberg, 2004, Scandinavian journal of primary health care.

Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project.

J. Ranstam, L. Råstam, U. Lindblad, 1999, Diabetes, obesity & metabolism.

Residual risk for acute stroke in patients with type 2 diabetes and hypertension in primary care: Skaraborg Hypertension and Diabetes Project

L. Råstam, U. Lindblad, B. Gullberg, 2006, Diabetes, obesity & metabolism.

Antihypertensive drug treatment in a Swedish community: Skaraborg hypertension and diabetes project

J. Ranstam, L. Råstam, U. Lindblad, 2002, Pharmacoepidemiology and drug safety.

Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and diabetes project.

L. Groop, J. Ranstam, L. Råstam, 1999, Journal of hypertension.

Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project

J. Ranstam, L. Råstam, U. Lindblad, 2001, Diabetes, obesity & metabolism.